tradingkey.logo
tradingkey.logo
Suchen

Oncology Institute Inc

TOIIW
Zur Watchlist hinzufügen
0.042USD
+0.002+4.76%
Handelsschluss 07/06, 16:00ETKurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM

mehr Informationen über Oncology Institute Inc Unternehmen

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Inc Informationen

BörsenkürzelTOIIW
Name des UnternehmensOncology Institute Inc
IPO-datumMar 13, 2020
CEODr. Daniel Virnich, M.D.
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse18000 Studebaker Rd
StadtCERRITOS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl90703
Telefon15627353226
Websitehttps://theoncologyinstitute.com/
BörsenkürzelTOIIW
IPO-datumMar 13, 2020
CEODr. Daniel Virnich, M.D.

Führungskräfte von Oncology Institute Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Oncology Institute Inc?

Die fünf größten Anteilseigner von Oncology Institute Inc sind: Mr. Mark L. Pacala